LRRC15-targeting ADC SOT106 gains FDA fast track and orphan status for sarcomas, showing preclinical promise as it heads into a first-in-human trial.
|Videos|November 1, 2016
Advanced Soft Tissue Sarcoma with Brian Van Tine, MD, PhD Case 2
Advanced Soft Tissue Sarcoma with Brian Van Tine, MD, PhD
Advertisement
Case Scenario 2:
- The patient is a 61 year-old Caucasian woman, diagnosed with uterine leiomyosarcoma (LMS) metastatic to the peritoneum and lungs.
- The tumor is 11 cm in diameter
- Her performance status is 1
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Denosumab Biosimilar Approved For Existing Oncology Indications
2
Plinabulin Receives FDA Fast Track Designation in Post-ICI NSCLC
3
FDA Oncology Recap: Approvals, Designations, and Decisions in September 2026
4
Giredestrant Plus Everolimus Improves PFS in ER+ Advanced Breast Cancer
5